Andy MacMillan thinks business analysts, not IT and not the vendors, should own the layer where enterprise AI gets its ...

The quest for true randomness has roots in cryptography and is a rabbit hole that gets surprisingly deep with alarmingly ...

Learn how to use Grok 4.3 in 2026 with this beginner's guide covering advanced workflows, task automation, and role-based ...

Are magic links secure? A security analyst breaks down token entropy, replay protection, expiry, device binding, and email compromise risks for MojoAuth users.

NEW YORK, April 27 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab is using artificial intelligence to slash by half the time it ‌takes to generate new leads for developing drugs, the company's ...

Email signature generator EmailSignatures lets you create polished, professional email signatures in minutes. More than simply bolding your name, you can add your company’s logo, your social links — ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

If a hacker or scammer has access to your email, every account connected to it is at risk. We show you how to protect yourself fast. I review privacy tools like hardware security keys, password ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

AI-generated dossiers from the Jmail team. AI-generated dossiers from the Jmail team. is the Verge’s weekend editor. He has over 18 years of experience, including 10 years as managing editor at ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...